Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans.
about
Endothelial Dysfunction: Clinical Implications in Cardiovascular Disease and Therapeutic ApproachesCoronary microvascular dysfunction in women: an overview of diagnostic strategiesCardiovascular changes in atherosclerotic ApoE-deficient mice exposed to Co60 (γ) radiationEndothelin and its antagonists in hypertension: can we foresee the future?Clinical methods for the evaluation of endothelial function-- a focus on resistance arteries.Comparison of effect between nitrates and calcium channel antagonist on vascular function in patients with normal or mildly diseased coronary arteries.Single nucleotide polymorphisms associated with abnormal coronary microvascular function.Tendency to angry rumination predicts stress-provoked endothelin-1 increase in patients with coronary artery diseaseTesting for endothelial dysfunction.Endothelial function as a functional expression of cardiovascular risk factors.Endothelial dysfunction and atherosclerosis: endothelin receptor antagonists as novel therapeutics.Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis.Is there a role for endothelin antagonists in diabetic renal disease?Role of endothelin in human hypertension.MRTF-A steers an epigenetic complex to activate endothelin-induced pro-inflammatory transcription in vascular smooth muscle cellsThe therapeutic potential of endothelin receptor antagonists in cardiovascular disease.Endothelial function, endothelin-1, and fibrinogen in young women using the vaginal contraceptive ring.Depression predicts elevated endothelin-1 in patients with coronary artery disease.Effect of Controlling Hypercholesterolemia on Myocardial Ischemia.Severe depressive symptoms are associated with elevated endothelin-1 in younger patients with acute coronary syndrome.Systemic inflammatory response induced by particulate matter air pollution: the importance of bone-marrow stimulation.Autonomic contribution to endothelin-1 increase during laboratory anger-recall stress in patients with coronary artery diseaseRole of ET-1 in the regulation of coronary circulation.Shrinkage of human coronary arteries is an important determinant of de novo atherosclerotic luminal stenosis: an in vivo intravascular ultrasound study.Functional behavior and gene expression of magnetic nanoparticle-loaded primary endothelial cells for targeting vascular stents.Three Preservation Solutions for Cold Storage of Heart Allografts: A Systematic Review and Meta-Analysis.Elevated plasma endothelin-1 and pulmonary arterial pressure in children exposed to air pollution.Cocaine Abstinence and Reduced Use Associated With Lowered Marker of Endothelial Dysfunction in African Americans: A Preliminary Study.Coronary endothelial function testing provides superior discrimination compared with standard clinical risk scoring in prediction of cardiovascular eventsEstrogen-induced improvement in coronary flow responses during atrial pacing in relation to endothelin-1 levels in postmenopausal women without coronary diseaseSex-Specific Genetic Variants are Associated With Coronary Endothelial Dysfunction.Lipoprotein-associated phospholipase A(2) : review of its role as a marker and a potential participant in coronary endothelial dysfunction.Coronary endothelial dysfunction in patients with early coronary artery disease is associated with the increase in intravascular lipid core plaqueThe Evaluation of the Impact of Age, Skin Tags, Metabolic Syndrome, Body Mass Index, and Smoking on Homocysteine, Endothelin-1, High-sensitive C-reactive Protein, and on the HeartRole of endothelin in microvascular dysfunction following percutaneous coronary intervention for non-ST elevation acute coronary syndromes: a single-centre randomised controlled trialEfficacy and safety of atrasentan in patients with cardiovascular risk and early atherosclerosisA review of methods for assessment of coronary microvascular disease in both clinical and experimental settings.Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis.Endothelial dysfunction occurs prior to clinical evidence of polycystic kidney disease.Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia.
P2860
Q26785504-0931F961-5668-4B9C-8371-59EE47800CE6Q27024500-A967D678-8629-4EB9-9D15-08835365A1F6Q28384658-94936590-DF65-4014-82C0-31940668E88AQ30612015-A717957F-08C4-4FE8-966C-745A8E3D8FE5Q33242082-221A40AC-9BA0-4B18-92B0-FFF9BC941DC7Q33327002-A3B26CDF-9CAE-4B00-A8C5-92E4CC4164CDQ33596941-5D1E5B66-73E8-4B3C-89BA-047F95EB4BE6Q33857649-9B23ADEE-3A78-4440-9D2A-A91D6B38BB06Q34008359-FB38CD01-C346-48BA-B0E0-83E22E3C1631Q34027133-23109CCE-6616-4619-8F4F-9A74337ACAFCQ34028426-5CF57B80-31EC-47B3-87CC-ECFC312EECC0Q34157915-673A5AFF-BD3D-40BF-963F-76C8FE93F196Q34163153-1B4B7445-CB3A-4212-A76E-EACC8E429BC1Q34210942-4D4C6BF6-BD4C-4595-A946-4E1C195FEEFAQ34249545-A67086FE-2993-401C-B3FD-15F6A12828EBQ34317655-5A0C21D8-A336-4C87-9046-16269125C965Q34447839-DB221026-8E5F-4F15-9279-0F11AFC5575BQ34468833-3C1C5B98-BBEC-4AC9-BD81-B51CF5FF6C06Q34518020-C5F58FB5-F967-4DDA-9480-C5CC07CD7334Q34613688-C682BB31-5864-4FD0-956D-0D31DAC0F62BQ34979088-50BA8AE4-5BEA-4432-88E0-ED59802C5F88Q35017010-58D052E1-DB88-4326-979A-E78E4C6B09C3Q35168412-AE8ADE09-C251-4986-B78A-F2F367DAF73DQ35366688-FD2543AB-2463-448F-8AE6-BD4799CD81D4Q35703384-FE7452AA-D691-47AF-884B-13D304CB1446Q35829809-DB5F8162-8967-4971-A853-7D05D54CDFB0Q35925483-DC5C3098-564C-43C1-AE2C-039774396D4CQ36458456-A017C3E8-5725-438E-9CEC-4EB7F64E6CC7Q36772302-44D805EC-4F4A-4F24-ABA5-D8E547D2E04AQ36835892-9105C456-8FF6-4B23-A448-58910AFB257DQ36877201-66A729E4-C8E3-40C5-934B-F58601DBB68DQ36913022-B984DAD5-8A68-4D8F-BDD9-33D17C5C99FCQ37009785-D8171DE2-AEF2-4950-9C15-18214BFF2E04Q37054362-87E34A83-8911-4657-AEBD-4911CE90FC4DQ37156436-471EE7C9-C56A-4696-BD7E-C500A35FB43DQ37174006-2F817A2F-A2DA-4EBC-9924-CF18FAFB7500Q37176886-B0B283E0-AACA-40DF-99AB-B3382783B57AQ37227727-6727AA5F-A8EF-4BF6-BB43-10FF03E20511Q37329086-2C1A75A2-8D62-40A0-90A3-CA7C6E93D42BQ37380464-DE188218-C012-46A5-85A9-629AEE1F54DE
P2860
Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans.
@en
type
label
Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans.
@en
prefLabel
Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans.
@en
P2093
P356
P1433
P1476
Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans.
@en
P2093
Burnett JC Jr
Garratt KN
Holmes DR Jr
Nishimura RA
P304
P356
10.1161/01.CIR.92.9.2426
P407
P577
1995-11-01T00:00:00Z